 | Up a level |
Velayutham, Naveen Kumar and Thamaraikani, Tamilanban and Wahab, Shadma and Khalid, Mohammad and Gobinath, Ramachawolran and Abullais, Shahabe Saquib and Wong, Ling Shing and Mahendran, Sekar and Gan, Siew Hua and Ebenezer, Angel Jemima and Ravikumar, Mrinalini and Vetriselvan, Subramaniyan * and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Jeyabalan, Srikanth (2024) Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 15. ISSN 1663-9812
Muhamad Azrul, Amir Yusri and Mahendran, Sekar and Wong, Ling Shing and Gan, Siew Hua and Ravi, Subban and Vetriselvan, Subramaniyan and Nur Najihah, Izzati Mat Rani and Chidambaram, Kumarappan and Begum, M Yasmin and Ramar, Mohankumar and Sher Zaman, Safi and Siddharthan, Selvaraj and Wu, Yuan Seng * and Revathy, Palanisamy and Fuloria, Shivkanya and Fuloria, Neeraj Kumar and Lum, Pei Teng and Sinouvassane, Djearamane (2023) Celastrol: A Potential Natural Lead Molecule for New Drug Design, Development and Therapy for Memory Impairment. Drug Design, Development and Therapy, 17. ISSN 1177-8881
Subramanian, Arunkumar and Tamilanban, T and Mahendran, Sekar and Begum, M Yasmin and Atiya, Akhtar and Gobinath, Ramachawolran and Wong, Ling Shing and Subramaniyan, Vetriselvan and Gan, Siew Hua and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Chinni, Suresh V and Fuloria, Shivkanya and Fuloria, Neeraj Kumar (2023) Neuroprotective potential of Marsilea quadrifolia Linn against monosodium glutamate-induced excitotoxicity in rats. Frontiers in Pharmacology, 14. ISSN 1663-9812
Velayutham, Naveen Kumar and Thamaraikani, Tamilanban and Wahab, Shadma and Khalid, Mohammad and Gobinath, Ramachawolran and Abullais, Shahabe Saquib and Wong, Ling Shing and Mahendran, Sekar and Gan, Siew Hua and Ebenezer, Angel Jemima and Ravikumar, Mrinalini and Subramaniyan, Vetriselvan and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Jeyabalan, Srikanth (2023) Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 14. ISSN 1663-9812
